Global IVIG Market Research Report 2023

Publisher Name :
Date: 05-Dec-2023
No. of pages: 106
Inquire Before Buying

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global IVIG market with multiple angles, which provides sufficient supports to readers' strategy and decision making.

By Company

- Green Cross

- BSV

- Hualan Bio

- RAAS

- YUAN DA SHUYANG

- Kangbao Bio

- Tiantan Bio

- Taibang Bio

- Weiguang Bio

- SIBP

- TONROL

- RUIDE Bio

- BOYA Bio

- RUIDE Bio

- Xinxing Medicine

- Weilun Bio

- WIBP

Segment by Type

- Injection IVIG

- Lyophilized Powder IVIG

Segment by Application

- Multiple Sclerosis(MS)

- Myasthenia Gravis(MG)

- Multifocal Motor Neuropathy(MMN)

- Multifocal Acquired Sensory and Motor Neuropathy(MADSAM)

- Dermatomyositis

- Polymyositis

Consumption By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - China Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

The IVIG report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)

Chapter 2: Manufacturers' Competition Patterns

Chapter 3: Country Level Sales Analysis

Chapter 4: Product Type Analysis

Chapter 5: Product Application Analysis

Chapter 6: Manufacturers' Outline

Chapter 7: Industry Chain, Market Channel and Customer Analysis

Chapter 8: Market Opportunities and Challenges

Chapter 9: Market Conclusions

Chapter 10: Research Methodology and Data Source

Global IVIG Market Research Report 2023

Table of Contents
1 IVIG Market Overview
1.1 Product Overview and Scope of IVIG
1.2 IVIG Segment by Type
1.2.1 Global IVIG Market Value Comparison by Type (2023-2029)
1.2.2 Injection IVIG
1.2.3 Lyophilized Powder IVIG
1.3 IVIG Segment by Application
1.3.1 Global IVIG Market Value by Application: (2023-2029)
1.3.2 Multiple Sclerosis(MS)
1.3.3 Myasthenia Gravis(MG)
1.3.4 Multifocal Motor Neuropathy(MMN)
1.3.5 Multifocal Acquired Sensory and Motor Neuropathy(MADSAM)
1.3.6 Dermatomyositis
1.3.7 Polymyositis
1.4 Global IVIG Market Size Estimates and Forecasts
1.4.1 Global IVIG Revenue 2018-2029
1.4.2 Global IVIG Sales 2018-2029
1.4.3 Global IVIG Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 IVIG Market Competition by Manufacturers
2.1 Global IVIG Sales Market Share by Manufacturers (2018-2023)
2.2 Global IVIG Revenue Market Share by Manufacturers (2018-2023)
2.3 Global IVIG Average Price by Manufacturers (2018-2023)
2.4 Global IVIG Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of IVIG, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of IVIG, Product Type & Application
2.7 IVIG Market Competitive Situation and Trends
2.7.1 IVIG Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest IVIG Players Market Share by Revenue
2.7.3 Global IVIG Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 IVIG Retrospective Market Scenario by Region
3.1 Global IVIG Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global IVIG Global IVIG Sales by Region: 2018-2029
3.2.1 Global IVIG Sales by Region: 2018-2023
3.2.2 Global IVIG Sales by Region: 2024-2029
3.3 Global IVIG Global IVIG Revenue by Region: 2018-2029
3.3.1 Global IVIG Revenue by Region: 2018-2023
3.3.2 Global IVIG Revenue by Region: 2024-2029
3.4 North America IVIG Market Facts & Figures by Country
3.4.1 North America IVIG Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America IVIG Sales by Country (2018-2029)
3.4.3 North America IVIG Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe IVIG Market Facts & Figures by Country
3.5.1 Europe IVIG Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe IVIG Sales by Country (2018-2029)
3.5.3 Europe IVIG Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific IVIG Market Facts & Figures by Country
3.6.1 Asia Pacific IVIG Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific IVIG Sales by Country (2018-2029)
3.6.3 Asia Pacific IVIG Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America IVIG Market Facts & Figures by Country
3.7.1 Latin America IVIG Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America IVIG Sales by Country (2018-2029)
3.7.3 Latin America IVIG Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa IVIG Market Facts & Figures by Country
3.8.1 Middle East and Africa IVIG Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa IVIG Sales by Country (2018-2029)
3.8.3 Middle East and Africa IVIG Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global IVIG Sales by Type (2018-2029)
4.1.1 Global IVIG Sales by Type (2018-2023)
4.1.2 Global IVIG Sales by Type (2024-2029)
4.1.3 Global IVIG Sales Market Share by Type (2018-2029)
4.2 Global IVIG Revenue by Type (2018-2029)
4.2.1 Global IVIG Revenue by Type (2018-2023)
4.2.2 Global IVIG Revenue by Type (2024-2029)
4.2.3 Global IVIG Revenue Market Share by Type (2018-2029)
4.3 Global IVIG Price by Type (2018-2029)
5 Segment by Application
5.1 Global IVIG Sales by Application (2018-2029)
5.1.1 Global IVIG Sales by Application (2018-2023)
5.1.2 Global IVIG Sales by Application (2024-2029)
5.1.3 Global IVIG Sales Market Share by Application (2018-2029)
5.2 Global IVIG Revenue by Application (2018-2029)
5.2.1 Global IVIG Revenue by Application (2018-2023)
5.2.2 Global IVIG Revenue by Application (2024-2029)
5.2.3 Global IVIG Revenue Market Share by Application (2018-2029)
5.3 Global IVIG Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Green Cross
6.1.1 Green Cross Corporation Information
6.1.2 Green Cross Description and Business Overview
6.1.3 Green Cross IVIG Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Green Cross IVIG Product Portfolio
6.1.5 Green Cross Recent Developments/Updates
6.2 BSV
6.2.1 BSV Corporation Information
6.2.2 BSV Description and Business Overview
6.2.3 BSV IVIG Sales, Revenue and Gross Margin (2018-2023)
6.2.4 BSV IVIG Product Portfolio
6.2.5 BSV Recent Developments/Updates
6.3 Hualan Bio
6.3.1 Hualan Bio Corporation Information
6.3.2 Hualan Bio Description and Business Overview
6.3.3 Hualan Bio IVIG Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Hualan Bio IVIG Product Portfolio
6.3.5 Hualan Bio Recent Developments/Updates
6.4 RAAS
6.4.1 RAAS Corporation Information
6.4.2 RAAS Description and Business Overview
6.4.3 RAAS IVIG Sales, Revenue and Gross Margin (2018-2023)
6.4.4 RAAS IVIG Product Portfolio
6.4.5 RAAS Recent Developments/Updates
6.5 YUAN DA SHUYANG
6.5.1 YUAN DA SHUYANG Corporation Information
6.5.2 YUAN DA SHUYANG Description and Business Overview
6.5.3 YUAN DA SHUYANG IVIG Sales, Revenue and Gross Margin (2018-2023)
6.5.4 YUAN DA SHUYANG IVIG Product Portfolio
6.5.5 YUAN DA SHUYANG Recent Developments/Updates
6.6 Kangbao Bio
6.6.1 Kangbao Bio Corporation Information
6.6.2 Kangbao Bio Description and Business Overview
6.6.3 Kangbao Bio IVIG Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Kangbao Bio IVIG Product Portfolio
6.6.5 Kangbao Bio Recent Developments/Updates
6.7 Tiantan Bio
6.6.1 Tiantan Bio Corporation Information
6.6.2 Tiantan Bio Description and Business Overview
6.6.3 Tiantan Bio IVIG Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Tiantan Bio IVIG Product Portfolio
6.7.5 Tiantan Bio Recent Developments/Updates
6.8 Taibang Bio
6.8.1 Taibang Bio Corporation Information
6.8.2 Taibang Bio Description and Business Overview
6.8.3 Taibang Bio IVIG Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Taibang Bio IVIG Product Portfolio
6.8.5 Taibang Bio Recent Developments/Updates
6.9 Weiguang Bio
6.9.1 Weiguang Bio Corporation Information
6.9.2 Weiguang Bio Description and Business Overview
6.9.3 Weiguang Bio IVIG Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Weiguang Bio IVIG Product Portfolio
6.9.5 Weiguang Bio Recent Developments/Updates
6.10 SIBP
6.10.1 SIBP Corporation Information
6.10.2 SIBP Description and Business Overview
6.10.3 SIBP IVIG Sales, Revenue and Gross Margin (2018-2023)
6.10.4 SIBP IVIG Product Portfolio
6.10.5 SIBP Recent Developments/Updates
6.11 TONROL
6.11.1 TONROL Corporation Information
6.11.2 TONROL IVIG Description and Business Overview
6.11.3 TONROL IVIG Sales, Revenue and Gross Margin (2018-2023)
6.11.4 TONROL IVIG Product Portfolio
6.11.5 TONROL Recent Developments/Updates
6.12 RUIDE Bio
6.12.1 RUIDE Bio Corporation Information
6.12.2 RUIDE Bio IVIG Description and Business Overview
6.12.3 RUIDE Bio IVIG Sales, Revenue and Gross Margin (2018-2023)
6.12.4 RUIDE Bio IVIG Product Portfolio
6.12.5 RUIDE Bio Recent Developments/Updates
6.13 BOYA Bio
6.13.1 BOYA Bio Corporation Information
6.13.2 BOYA Bio IVIG Description and Business Overview
6.13.3 BOYA Bio IVIG Sales, Revenue and Gross Margin (2018-2023)
6.13.4 BOYA Bio IVIG Product Portfolio
6.13.5 BOYA Bio Recent Developments/Updates
6.14 RUIDE Bio
6.14.1 RUIDE Bio Corporation Information
6.14.2 RUIDE Bio IVIG Description and Business Overview
6.14.3 RUIDE Bio IVIG Sales, Revenue and Gross Margin (2018-2023)
6.14.4 RUIDE Bio IVIG Product Portfolio
6.14.5 RUIDE Bio Recent Developments/Updates
6.15 Xinxing Medicine
6.15.1 Xinxing Medicine Corporation Information
6.15.2 Xinxing Medicine IVIG Description and Business Overview
6.15.3 Xinxing Medicine IVIG Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Xinxing Medicine IVIG Product Portfolio
6.15.5 Xinxing Medicine Recent Developments/Updates
6.16 Weilun Bio
6.16.1 Weilun Bio Corporation Information
6.16.2 Weilun Bio IVIG Description and Business Overview
6.16.3 Weilun Bio IVIG Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Weilun Bio IVIG Product Portfolio
6.16.5 Weilun Bio Recent Developments/Updates
6.17 WIBP
6.17.1 WIBP Corporation Information
6.17.2 WIBP IVIG Description and Business Overview
6.17.3 WIBP IVIG Sales, Revenue and Gross Margin (2018-2023)
6.17.4 WIBP IVIG Product Portfolio
6.17.5 WIBP Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 IVIG Industry Chain Analysis
7.2 IVIG Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 IVIG Production Mode & Process
7.4 IVIG Sales and Marketing
7.4.1 IVIG Sales Channels
7.4.2 IVIG Distributors
7.5 IVIG Customers
8 IVIG Market Dynamics
8.1 IVIG Industry Trends
8.2 IVIG Market Drivers
8.3 IVIG Market Challenges
8.4 IVIG Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global IVIG Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global IVIG Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global IVIG Market Competitive Situation by Manufacturers in 2022
Table 4. Global IVIG Sales (K Pcs) of Key Manufacturers (2018-2023)
Table 5. Global IVIG Sales Market Share by Manufacturers (2018-2023)
Table 6. Global IVIG Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global IVIG Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market IVIG Average Price (USD/Pcs) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of IVIG, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of IVIG, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of IVIG, Product Type & Application
Table 12. Global Key Manufacturers of IVIG, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global IVIG by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IVIG as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global IVIG Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global IVIG Sales by Region (2018-2023) & (K Pcs)
Table 18. Global IVIG Sales Market Share by Region (2018-2023)
Table 19. Global IVIG Sales by Region (2024-2029) & (K Pcs)
Table 20. Global IVIG Sales Market Share by Region (2024-2029)
Table 21. Global IVIG Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global IVIG Revenue Market Share by Region (2018-2023)
Table 23. Global IVIG Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global IVIG Revenue Market Share by Region (2024-2029)
Table 25. North America IVIG Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America IVIG Sales by Country (2018-2023) & (K Pcs)
Table 27. North America IVIG Sales by Country (2024-2029) & (K Pcs)
Table 28. North America IVIG Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America IVIG Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe IVIG Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe IVIG Sales by Country (2018-2023) & (K Pcs)
Table 32. Europe IVIG Sales by Country (2024-2029) & (K Pcs)
Table 33. Europe IVIG Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe IVIG Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific IVIG Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific IVIG Sales by Region (2018-2023) & (K Pcs)
Table 37. Asia Pacific IVIG Sales by Region (2024-2029) & (K Pcs)
Table 38. Asia Pacific IVIG Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific IVIG Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America IVIG Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America IVIG Sales by Country (2018-2023) & (K Pcs)
Table 42. Latin America IVIG Sales by Country (2024-2029) & (K Pcs)
Table 43. Latin America IVIG Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America IVIG Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa IVIG Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa IVIG Sales by Country (2018-2023) & (K Pcs)
Table 47. Middle East & Africa IVIG Sales by Country (2024-2029) & (K Pcs)
Table 48. Middle East & Africa IVIG Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa IVIG Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global IVIG Sales (K Pcs) by Type (2018-2023)
Table 51. Global IVIG Sales (K Pcs) by Type (2024-2029)
Table 52. Global IVIG Sales Market Share by Type (2018-2023)
Table 53. Global IVIG Sales Market Share by Type (2024-2029)
Table 54. Global IVIG Revenue (US$ Million) by Type (2018-2023)
Table 55. Global IVIG Revenue (US$ Million) by Type (2024-2029)
Table 56. Global IVIG Revenue Market Share by Type (2018-2023)
Table 57. Global IVIG Revenue Market Share by Type (2024-2029)
Table 58. Global IVIG Price (USD/Pcs) by Type (2018-2023)
Table 59. Global IVIG Price (USD/Pcs) by Type (2024-2029)
Table 60. Global IVIG Sales (K Pcs) by Application (2018-2023)
Table 61. Global IVIG Sales (K Pcs) by Application (2024-2029)
Table 62. Global IVIG Sales Market Share by Application (2018-2023)
Table 63. Global IVIG Sales Market Share by Application (2024-2029)
Table 64. Global IVIG Revenue (US$ Million) by Application (2018-2023)
Table 65. Global IVIG Revenue (US$ Million) by Application (2024-2029)
Table 66. Global IVIG Revenue Market Share by Application (2018-2023)
Table 67. Global IVIG Revenue Market Share by Application (2024-2029)
Table 68. Global IVIG Price (USD/Pcs) by Application (2018-2023)
Table 69. Global IVIG Price (USD/Pcs) by Application (2024-2029)
Table 70. Green Cross Corporation Information
Table 71. Green Cross Description and Business Overview
Table 72. Green Cross IVIG Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 73. Green Cross IVIG Product
Table 74. Green Cross Recent Developments/Updates
Table 75. BSV Corporation Information
Table 76. BSV Description and Business Overview
Table 77. BSV IVIG Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 78. BSV IVIG Product
Table 79. BSV Recent Developments/Updates
Table 80. Hualan Bio Corporation Information
Table 81. Hualan Bio Description and Business Overview
Table 82. Hualan Bio IVIG Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 83. Hualan Bio IVIG Product
Table 84. Hualan Bio Recent Developments/Updates
Table 85. RAAS Corporation Information
Table 86. RAAS Description and Business Overview
Table 87. RAAS IVIG Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 88. RAAS IVIG Product
Table 89. RAAS Recent Developments/Updates
Table 90. YUAN DA SHUYANG Corporation Information
Table 91. YUAN DA SHUYANG Description and Business Overview
Table 92. YUAN DA SHUYANG IVIG Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 93. YUAN DA SHUYANG IVIG Product
Table 94. YUAN DA SHUYANG Recent Developments/Updates
Table 95. Kangbao Bio Corporation Information
Table 96. Kangbao Bio Description and Business Overview
Table 97. Kangbao Bio IVIG Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 98. Kangbao Bio IVIG Product
Table 99. Kangbao Bio Recent Developments/Updates
Table 100. Tiantan Bio Corporation Information
Table 101. Tiantan Bio Description and Business Overview
Table 102. Tiantan Bio IVIG Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 103. Tiantan Bio IVIG Product
Table 104. Tiantan Bio Recent Developments/Updates
Table 105. Taibang Bio Corporation Information
Table 106. Taibang Bio Description and Business Overview
Table 107. Taibang Bio IVIG Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 108. Taibang Bio IVIG Product
Table 109. Taibang Bio Recent Developments/Updates
Table 110. Weiguang Bio Corporation Information
Table 111. Weiguang Bio Description and Business Overview
Table 112. Weiguang Bio IVIG Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 113. Weiguang Bio IVIG Product
Table 114. Weiguang Bio Recent Developments/Updates
Table 115. SIBP Corporation Information
Table 116. SIBP Description and Business Overview
Table 117. SIBP IVIG Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 118. SIBP IVIG Product
Table 119. SIBP Recent Developments/Updates
Table 120. TONROL Corporation Information
Table 121. TONROL Description and Business Overview
Table 122. TONROL IVIG Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 123. TONROL IVIG Product
Table 124. TONROL Recent Developments/Updates
Table 125. RUIDE Bio Corporation Information
Table 126. RUIDE Bio Description and Business Overview
Table 127. RUIDE Bio IVIG Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 128. RUIDE Bio IVIG Product
Table 129. RUIDE Bio Recent Developments/Updates
Table 130. BOYA Bio Corporation Information
Table 131. BOYA Bio Description and Business Overview
Table 132. BOYA Bio IVIG Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 133. BOYA Bio IVIG Product
Table 134. BOYA Bio Recent Developments/Updates
Table 135. RUIDE Bio Corporation Information
Table 136. RUIDE Bio Description and Business Overview
Table 137. RUIDE Bio IVIG Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 138. RUIDE Bio IVIG Product
Table 139. RUIDE Bio Recent Developments/Updates
Table 140. Xinxing Medicine Corporation Information
Table 141. Xinxing Medicine Description and Business Overview
Table 142. Xinxing Medicine IVIG Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 143. Xinxing Medicine IVIG Product
Table 144. Xinxing Medicine Recent Developments/Updates
Table 145. Weilun Bio Corporation Information
Table 146. Weilun Bio Description and Business Overview
Table 147. Weilun Bio IVIG Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 148. Weilun Bio IVIG Product
Table 149. Weilun Bio Recent Developments/Updates
Table 150. WIBP Corporation Information
Table 151. WIBP Description and Business Overview
Table 152. WIBP IVIG Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 153. WIBP IVIG Product
Table 154. WIBP Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. IVIG Distributors List
Table 158. IVIG Customers List
Table 159. IVIG Market Trends
Table 160. IVIG Market Drivers
Table 161. IVIG Market Challenges
Table 162. IVIG Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of IVIG
Figure 2. Global IVIG Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global IVIG Market Share by Type in 2022 & 2029
Figure 4. Injection IVIG Product Picture
Figure 5. Lyophilized Powder IVIG Product Picture
Figure 6. Global IVIG Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global IVIG Market Share by Application in 2022 & 2029
Figure 8. Multiple Sclerosis(MS)
Figure 9. Myasthenia Gravis(MG)
Figure 10. Multifocal Motor Neuropathy(MMN)
Figure 11. Multifocal Acquired Sensory and Motor Neuropathy(MADSAM)
Figure 12. Dermatomyositis
Figure 13. Polymyositis
Figure 14. Global IVIG Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global IVIG Market Size (2018-2029) & (US$ Million)
Figure 16. Global IVIG Sales (2018-2029) & (K Pcs)
Figure 17. Global IVIG Average Price (USD/Pcs) & (2018-2029)
Figure 18. IVIG Report Years Considered
Figure 19. IVIG Sales Share by Manufacturers in 2022
Figure 20. Global IVIG Revenue Share by Manufacturers in 2022
Figure 21. The Global 5 and 10 Largest IVIG Players: Market Share by Revenue in 2022
Figure 22. IVIG Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 23. Global IVIG Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 24. North America IVIG Sales Market Share by Country (2018-2029)
Figure 25. North America IVIG Revenue Market Share by Country (2018-2029)
Figure 26. U.S. IVIG Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Canada IVIG Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. Europe IVIG Sales Market Share by Country (2018-2029)
Figure 29. Europe IVIG Revenue Market Share by Country (2018-2029)
Figure 30. Germany IVIG Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. France IVIG Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. U.K. IVIG Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Italy IVIG Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Russia IVIG Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Asia Pacific IVIG Sales Market Share by Region (2018-2029)
Figure 36. Asia Pacific IVIG Revenue Market Share by Region (2018-2029)
Figure 37. China IVIG Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Japan IVIG Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. South Korea IVIG Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. India IVIG Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Australia IVIG Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. China Taiwan IVIG Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Indonesia IVIG Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Thailand IVIG Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Malaysia IVIG Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Latin America IVIG Sales Market Share by Country (2018-2029)
Figure 47. Latin America IVIG Revenue Market Share by Country (2018-2029)
Figure 48. Mexico IVIG Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Brazil IVIG Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Argentina IVIG Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Middle East & Africa IVIG Sales Market Share by Country (2018-2029)
Figure 52. Middle East & Africa IVIG Revenue Market Share by Country (2018-2029)
Figure 53. Turkey IVIG Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia IVIG Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. UAE IVIG Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 56. Global Sales Market Share of IVIG by Type (2018-2029)
Figure 57. Global Revenue Market Share of IVIG by Type (2018-2029)
Figure 58. Global IVIG Price (USD/Pcs) by Type (2018-2029)
Figure 59. Global Sales Market Share of IVIG by Application (2018-2029)
Figure 60. Global Revenue Market Share of IVIG by Application (2018-2029)
Figure 61. Global IVIG Price (USD/Pcs) by Application (2018-2029)
Figure 62. IVIG Value Chain
Figure 63. IVIG Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
  • Global IVIG Market Research Report 2023
    Published: 05-Dec-2023        Price: US 2900 Onwards        Pages: 106
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global IVIG market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Green Cross - BSV - Hualan Bio - RAAS - YUAN DA SHUYANG - Kangbao Bio - Tiantan Bio - Taibang Bio - Weiguang Bio - SIBP - TONR......
  • Global Blood Conservation System Market Report, History and Forecast 2018-2029, Breakdown Data by Manufacturers, Key Regions, Types and Application
    Published: 27-Sep-2023        Price: US 3350 Onwards        Pages: 96
    Surgical blood conservation techniques are used to reduce patient exposure to allogeneic blood during and after surgery. Techniques include preoperative autologous donation, intraoperative hemodilution, and blood salvage (also called cell salvage) during surgery. Blood Conservation System report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Blood Conservation System market is projected to reach US$ million in 2029, increasi......
  • Global IVIG Market Insights, Forecast to 2029
    Published: 14-Jun-2023        Price: US 4900 Onwards        Pages: 116
    The global IVIG market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. The US & Canada market for IVIG is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029. The China market for IVIG is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the fore......
  • Global IVIG Market Research Report 2023 (Status and Outlook)
    Published: 10-May-2023        Price: US 2800 Onwards        Pages: 139
    Report Overview Bosson Research's latest report provides a deep insight into the global IVIG market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter's five forces analysis, value chain analysis, etc. The analysis helps the reader to shape the competition within the industries and strateg......
  • Global Blood Conservation System Market Research Report 2023, Forecast to 2028
    Published: 23-Feb-2023        Price: US 2680 Onwards        Pages: 132
    Blood conservation is a group of techniques used to minimize the need for blood used during treatment for a health condition. For individuals who desire bloodless surgery, which is any surgical procedure where no blood products foreign to the patient are used, blood conservation is essential. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data fo......
  • Global Blood Conservation System Professional Survey Report 2023, Forecast to 2028
    Published: 23-Feb-2023        Price: US 3280 Onwards        Pages: 101
    Blood conservation is a group of techniques used to minimize the need for blood used during treatment for a health condition. For individuals who desire bloodless surgery, which is any surgical procedure where no blood products foreign to the patient are used, blood conservation is essential. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data fo......
  • Global Blood Conservation System Market Growth 2023-2029
    Published: 02-Feb-2023        Price: US 3660 Onwards        Pages: 99
    LPI (LP Information)' newest research report, the "Blood Conservation System Industry Forecast" looks at past sales and reviews total world Blood Conservation System sales in 2022, providing a comprehensive analysis by region and market sector of projected Blood Conservation System sales for 2023 through 2029. With Blood Conservation System sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Blood Conservation System in......
  • Global Blood Conservation System Market Research Report 2023
    Published: 31-Jan-2023        Price: US 2900 Onwards        Pages: 93
    The global Blood Conservation System market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. North American market for Blood Conservation System is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029. Asia-P......
  • Blood Conservation System Market, Global Outlook and Forecast 2023-2029
    Published: 31-Jan-2023        Price: US 3250 Onwards        Pages: 72
    This report aims to provide a comprehensive presentation of the global market for Blood Conservation System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood Conservation System. This report contains market size and forecasts of Blood Conservation System in global, including the following market inform......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs